Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.
December S&P 500 futures (ESZ22) are trending down -0.16% this morning after three major US benchmark indices finished the regular session in the red as market participants fretted over Federal Reserve...
December S&P 500 futures (ESZ22) are trending down -0.68% this morning after the Dow Jones Industrial Average and S&P 500 index continued to fall deeper into bear-market territory as investors digested...
IBIO earnings call for the period ending March 31, 2022.
BRYAN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...
BRYAN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...
BRYAN, Texas, March 11, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...
Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration, today announced the appointment of...